Hemoglobin A1c in youth and adults with cystic fibrosis related diabetes decreases after elexacaftor-tezacaftor-ivacaftor
Colleen Wood, Amir Moheet, Tim Vigers, Andrea Granados, Andrea Lorenz, Elinor Hanley, Edith T. Zemanick, Christine L. Chan
Topics & Concepts
IvacaftorMedicineCystic fibrosisCystic fibrosis-related diabetesDiabetes mellitusHemoglobinInternal medicineType 2 diabetesEndocrinologyCystic fibrosis transmembrane conductance regulatorImpaired glucose toleranceCystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseases